Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US7247318B2 · kind B2 · utility
22Cited by
16References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 2002 |
| Grant date | Jul 24, 2007 |
| Priority date | — |
| Expiry date | May 28, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to oral modified/controlled release drug formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak concentration is lower than that provided by the reference standard for immediate release formulations of the drug, and the duration of effect falls rapidly at the end of the dosing interval.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.